{"entity":{"type":"insider","cik":"0001405288","url":"/insider/0001405288","json_url":"/insider/0001405288.json","name":"FOUSE JACQUALYN A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":12,"first":"2011-06-14","last":"2025-04-10","span_basis":"filed_date"},"name_variants":[{"name":"FOUSE JACQUALYN A","source":"filing","n_filings":12,"first_seen":"2011-06-14","last_seen":"2025-04-10"}],"transactions":[{"id":4287050,"accession":"0001439222-25-000029","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-25-000029","line_url":"/filing/0001439222-25-000029#line-2","is_derivative":false,"issuer_cik":"0001405288","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001405288","owner_cik":"0001405288","owner_name":"FOUSE JACQUALYN A","owner_display_name":"FOUSE JACQUALYN A","owner_url":"/insider/0001405288","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7497.0,"shares_display":"7,497","price_per_share":25.9,"price_display":"25.90","price_state":"stated","total_value":194172.3,"total_display":"194,172.30","total_whole":"194,172","shares_owned_after":149220.0,"shares_owned_after_display":"149,220","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-10","filed_date":"2025-04-10","scope":"insider"},{"id":2691255,"accession":"0001439222-24-000063","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-24-000063","line_url":"/filing/0001439222-24-000063#line-2","is_derivative":false,"issuer_cik":"0001405288","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001405288","owner_cik":"0001405288","owner_name":"FOUSE JACQUALYN A","owner_display_name":"FOUSE JACQUALYN A","owner_url":"/insider/0001405288","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7791.0,"shares_display":"7,791","price_per_share":27.55,"price_display":"27.55","price_state":"stated","total_value":214642.05,"total_display":"214,642.05","total_whole":"214,642","shares_owned_after":137396.0,"shares_owned_after_display":"137,396","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-10","filed_date":"2024-04-10","scope":"insider"},{"id":2629200,"accession":"0001439222-24-000016","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-24-000016","line_url":"/filing/0001439222-24-000016#line-2","is_derivative":false,"issuer_cik":"0001405288","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001405288","owner_cik":"0001405288","owner_name":"FOUSE JACQUALYN A","owner_display_name":"FOUSE JACQUALYN A","owner_url":"/insider/0001405288","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10722.0,"shares_display":"10,722","price_per_share":21.64,"price_display":"21.64","price_state":"stated","total_value":232024.08,"total_display":"232,024.08","total_whole":"232,024","shares_owned_after":129253.0,"shares_owned_after_display":"129,253","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-24","filed_date":"2024-01-24","scope":"insider"},{"id":2911393,"accession":"0001439222-24-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-24-000008","line_url":"/filing/0001439222-24-000008#line-2","is_derivative":false,"issuer_cik":"0001405288","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001405288","owner_cik":"0001405288","owner_name":"FOUSE JACQUALYN A","owner_display_name":"FOUSE JACQUALYN A","owner_url":"/insider/0001405288","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8391.0,"shares_display":"8,391","price_per_share":22.99,"price_display":"22.99","price_state":"stated","total_value":192909.09,"total_display":"192,909.09","total_whole":"192,909","shares_owned_after":116075.0,"shares_owned_after_display":"116,075","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-09","filed_date":"2024-01-09","scope":"insider"},{"id":7811827,"accession":"0001439222-23-000107","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-23-000107","line_url":"/filing/0001439222-23-000107#line-2","is_derivative":false,"issuer_cik":"0001405288","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001405288","owner_cik":"0001405288","owner_name":"FOUSE JACQUALYN A","owner_display_name":"FOUSE JACQUALYN A","owner_url":"/insider/0001405288","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10718.0,"shares_display":"10,718","price_per_share":28.36,"price_display":"28.36","price_state":"stated","total_value":303962.48,"total_display":"303,962.48","total_whole":"303,962","shares_owned_after":106966.0,"shares_owned_after_display":"106,966","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-30","filed_date":"2023-06-30","scope":"insider"},{"id":8079727,"accession":"0001439222-19-000025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001439222-19-000025","line_url":"/filing/0001439222-19-000025#line-1","is_derivative":false,"issuer_cik":"0001405288","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001405288","owner_cik":"0001405288","owner_name":"FOUSE JACQUALYN A","owner_display_name":"FOUSE JACQUALYN A","owner_url":"/insider/0001405288","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40322.0,"shares_display":"40,322","price_per_share":31.0,"price_display":"31.00","price_state":"stated","total_value":1249982.0,"total_display":"1,249,982.00","total_whole":"1,249,982","shares_owned_after":41722.0,"shares_owned_after_display":"41,722","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-13","filed_date":"2019-11-15","scope":"insider"},{"id":2535239,"accession":"0001209191-12-029489","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-029489","line_url":"/filing/0001209191-12-029489#line-1","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"CELGENE CORP /DE/","issuer_ticker":"CELG","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":"0001405288","owner_name":"FOUSE JACQUALYN A","owner_display_name":"FOUSE JACQUALYN A","owner_url":"/insider/0001405288","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"see remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":68.92,"price_display":"68.92","price_state":"stated","total_value":68920.0,"total_display":"68,920.00","total_whole":"68,920","shares_owned_after":9085.0,"shares_owned_after_display":"9,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-21","filed_date":"2012-05-21","scope":"insider"},{"id":9267991,"accession":"0001209191-11-058219","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-058219","line_url":"/filing/0001209191-11-058219#line-1","is_derivative":false,"issuer_cik":"0001405288","issuer_name":"CELGENE CORP /DE/","issuer_ticker":"CELG","issuer_name_source":null,"issuer_url":"/issuer/0001405288","owner_cik":"0001405288","owner_name":"FOUSE JACQUALYN A","owner_display_name":"FOUSE JACQUALYN A","owner_url":"/insider/0001405288","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":63.9154,"price_display":"63.92","price_state":"stated","total_value":63915.4,"total_display":"63,915.40","total_whole":"63,915","shares_owned_after":8085.0,"shares_owned_after_display":"8,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-01","filed_date":"2011-11-28","scope":"insider"},{"id":9133473,"accession":"0001209191-11-043157","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-043157","line_url":"/filing/0001209191-11-043157#line-1","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"CELGENE CORP /DE/","issuer_ticker":"CELG","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":"0001405288","owner_name":"FOUSE JACQUALYN A","owner_display_name":"FOUSE JACQUALYN A","owner_url":"/insider/0001405288","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":54.13,"price_display":"54.13","price_state":"stated","total_value":54130.0,"total_display":"54,130.00","total_whole":"54,130","shares_owned_after":7085.0,"shares_owned_after_display":"7,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-09","filed_date":"2011-08-09","scope":"insider"},{"id":9096492,"accession":"0001209191-11-042867","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-042867","line_url":"/filing/0001209191-11-042867#line-1","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"CELGENE CORP /DE/","issuer_ticker":"CELG","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":"0001405288","owner_name":"FOUSE JACQUALYN A","owner_display_name":"FOUSE JACQUALYN A","owner_url":"/insider/0001405288","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":55.75,"price_display":"55.75","price_state":"stated","total_value":55750.0,"total_display":"55,750.00","total_whole":"55,750","shares_owned_after":6085.0,"shares_owned_after_display":"6,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-05","filed_date":"2011-08-08","scope":"insider"},{"id":9193238,"accession":"0001209191-11-041982","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-041982","line_url":"/filing/0001209191-11-041982#line-1","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"CELGENE CORP /DE/","issuer_ticker":"CELG","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":"0001405288","owner_name":"FOUSE JACQUALYN A","owner_display_name":"FOUSE JACQUALYN A","owner_url":"/insider/0001405288","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":59.47,"price_display":"59.47","price_state":"stated","total_value":118940.0,"total_display":"118,940.00","total_whole":"118,940","shares_owned_after":5085.0,"shares_owned_after_display":"5,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-01","filed_date":"2011-08-02","scope":"insider"},{"id":9152492,"accession":"0001209191-11-034533","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-034533","line_url":"/filing/0001209191-11-034533#line-1","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"CELGENE CORP /DE/","issuer_ticker":"CELG","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":"0001405288","owner_name":"FOUSE JACQUALYN A","owner_display_name":"FOUSE JACQUALYN A","owner_url":"/insider/0001405288","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":58.256,"price_display":"58.26","price_state":"stated","total_value":116512.0,"total_display":"116,512.00","total_whole":"116,512","shares_owned_after":3085.0,"shares_owned_after_display":"3,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-14","filed_date":"2011-06-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001439222","name":"AGIOS PHARMACEUTICALS, INC.","url":"/issuer/0001439222","role":"Director, Officer (Chief Executive Officer)","n_filings":6,"first_seen":"2019-11-15","last_seen":"2025-04-10"},{"type":"issuer","type_label":"ISSUER","cik":"0000816284","name":"CELGENE CORP /DE/","url":"/issuer/0000816284","role":"Officer","n_filings":6,"first_seen":"2011-06-14","last_seen":"2012-05-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001405288","retrieved_at":"2026-08-24T14:53:31+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}